New Delhi, April 2 Alkem Laboratories Ltd announced on Thursday that it would almost double its investment to up to ₹1,036 crore for its proposed greenfield formulation manufacturing facility in Ujjain, Madhya Pradesh.The company's board of directors approved an increase in investment from up...
New Delhi, March 27 AAP MP Vikramjit Singh Sahney raised the issue of spurious medicines on Friday and expressed serious concerns about the growing threat of substandard and counterfeit medicines in the country.During the zero hour in the Rajya Sabha, he said the issue of manufacturing...
cdsco
central drugs standard control organisation
counterfeit medicines
drug quality standards
drug regulation
drug safety
himachal pradesh
india
medicine samples
paracetamol
pharmaceutical industry
pharmaceuticalmanufacturingpharmaceutical quality
spurious medicines
uttarakhand
New Delhi, March 19 The Central Drugs Standard Control Organisation (CDSCO) has issued comprehensive guidelines outlining a dossier-based approach for issuing and renewing drug manufacturing licenses, aimed at ensuring uniform product licensing and quality standards.The document, released last...
cdsco
central drugs standard control organisation
dossier-based licensing
drug licensing
drug regulatory authorities
drugs and cosmetics act
firm-facility details
india pharmaceutical sector
licensing requirements
pharmaceutical compliance
pharmaceuticalmanufacturingpharmaceutical quality standards
product-specific data
regulatory evaluation
regulatory guidelines
Jammu, March 14 Union Minister Jitendra Singh laid the foundation stone of a Rs 600 crore pharmaceutical manufacturing facility in the Kathua district on Saturday, in an effort to strengthen India's strategic capabilities in pharmaceutical manufacturing and reduce dependence on imports of...
amino cephalosporanic acid (aca)
antibiotics
biotechnology industry research assistance council (birac)
department of biotechnology
drug intermediates
employment
healthcare
india
india's pharmaceutical sector
jammu and kashmir
kathua district
orchid pharma
pharmaceuticalmanufacturing
production-linked incentive scheme
supply chain
Union Minister in the Prime Minister’s Office, Jitendra Singh, stated that India’s strong global standing under the leadership of Narendra Modi has enabled the country to effectively manage international challenges.Speaking to the media after attending the inauguration and ground-breaking...
antibiotics
diplomacy
domestic production
india
india_government
international relations
investment
jitendra singh
kathua district
lpg
narendra modi
orchid bio pharma
pharmaceuticalmanufacturing
self-reliant india
ukraine conflict
New Delhi, March 8 A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).Cipla USA, Inc, based in Warren (New Jersey), is recalling Nilotinib Capsules in...
anti-cancer medication
cancer treatment
cipla
cipla usa, inc
class iii recall
drug supply
generic medication
manufacturing defect
nilotinib
pharmaceutical industry
pharmaceuticalmanufacturingpharmaceutical recall
us food and drug administration (usfda)
us prescription drugs
warren (new jersey)
Visakhapatnam, February 27 Blue Jet Healthcare Ltd will break ground on Saturday on a Rs 2,300-crore greenfield pharmaceutical manufacturing facility at the Rambilli Industrial Park in the Anakapalli district of Andhra Pradesh, marking a major expansion of India's specialty pharma and CDMO...
anakapalli district
andhra pradesh
blue jet healthcare
cdmo
chemical manufacturing
contrast media intermediates
effluent treatment plant (etp)
greenfield facility
high-intensity sweeteners
india
multipurpose chemistry products
pharmaceuticalmanufacturing
rambilli industrial park
specialty pharma
zero liquid discharge (zld)
New Delhi, February 27 Drug maker Lupin announced on Friday that it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility in Goa.The company stated that it has received the EIR with a satisfactory Voluntary Action Indicated (VAI)...
Bengaluru, February 26 Cytiva, a Danaher company and a life sciences firm, announced on Thursday that it has expanded its Fast Trak process development and validation services facility here to support biopharmaceutical companies in India and the Asia-Pacific region.The expanded center...
asia-pacific region
bengaluru
biopharmaceutical development
bioprocessing
biotechnology
cytiva
danaher
downstream processing
india
pharmaceuticalmanufacturing
process development
process validation
scale-up operations
training programs
upstream processing
New Delhi, February 25 The Science Department's Technology Development Board on Wednesday approved financial assistance to Karnataka-based Biovet Pvt Ltd to develop and commercialize veterinary reproductive hormones at a dedicated manufacturing facility.These hormones include...
Mumbai, February 23 The Central Drugs Standard Control Organisation (CDSO) has conducted an audit of almost 90 per cent of cough syrup manufacturers in the country, and it hopes to eliminate the "problem" in cough syrup by the next season, a top official said on Monday.Speaking at the 11th...
audit
capa (corrective and preventive action)
central drugs standard control organisation
cough syrup
drugs controller general of india
good manufacturing practices
india
mumbai
pharmaceutical industry
pharmaceuticalmanufacturingpharmaceutical quality
quality control
regulatory compliance
risk-based inspection
New Delhi, February 23 The Delhi Police has uncovered a factory involved in the manufacturing and repackaging of spurious medicines and psychotropic substances near Patna, an official said on Monday.The operation took place during an investigation of an FIR registered under the NDPS Act at the...
New Delhi, February 22 Aurobindo Pharma aims to increase its production of Penicillin-G to over 10,000 metric tonnes annually over the next 12 months, according to company CFO S Subramanian.The Hyderabad-based drug manufacturer also expects its manufacturing plant in China to achieve EBITDA...
New Delhi, February 16 Alkem Laboratories said on Monday that the US health regulator has issued a Form 483 with six observations after inspecting the manufacturing unit of its wholly-owned subsidiary, located in Chakan.The US Food and Drug Administration (USFDA) completed a pre-approval...
alkem laboratories
bse
chakan
data integrity
drug firm
enzene biosciences
fd&c act
form 483
india
manufacturing unit
pharmaceutical industry
pharmaceuticalmanufacturing
quality systems
regulatory inspection
us food and drug administration (usfda)
New Delhi, February 10 Drug maker Cipla said that the US health regulator has issued Form 483 with two observations after inspecting a manufacturing facility of its US-based unit, InvaGen Pharmaceuticals, Inc.A Pre-Approval Inspection was conducted by the US Food and Drug Administration...